Review Article
Volume 12 Issue 5 - 2020
Meta-Analysis of the Beneficial Effects of Mindfulness-Based Interventions (MBIs) on the Neurological System and Prevalent Neurological Disorders
Abdullah Hafid1,2 and Nicholas A Kerna3*
1University of Health and Humanities, Tortola, BVI
2University of Science, Arts and Technology, Montserrat, BWI
3SMC Medical Research, Thailand
*Corresponding Author: Nicholas A Kerna, POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: April 08, 2020; Published: April 30, 2020


Mindfulness-based interventions (MBIs), such as yoga, meditation, and prayer, are utilized globally. Mindfulness meditation, yoga, and spirituality (prayer) result in diminished pain, enhanced physical movement, and improved quality of life (QoL) in those suffering from chronic illness. MBI has been found useful in treating the negative symptoms of schizophrenia. Positive results have been noted employing MBIs in attention-deficit/hyperactivity disorder (ADHD). MBIs reduced pain scores and improved QoL ratings in cancer and chronic pain patients. Meditation has been shown to ameliorate the response to stress and promote wellness. During meditation, specific brain regions are activated, indicative of opioidergic pathways. Yoga has emerged as an adjunctive treatment in schizophrenia. Prayer and spirituality are associated with a greater sense of confidence and self-esteem compared to those who do not embrace them. Spiritual belief and the use of prayer aid specific individuals in coping with daily stressors. Mindfulness practices are distinctive compared to other integrative therapies. However, further randomized control trails (RCTs) and meta-analyses are needed to determine clinically-applied protocols for MBIs in neurological disorders, neuropathic trauma, depression, nervousness, and a low QoL. This research indicates that mindfulness-based interventions (yoga, meditation, and prayer) are gaining acceptance, and their beneficial effects on the neurological system and prevalent neurological disorders hold promise for the future.

Keywords: Chronic Pain; Cognitive Decline; Meditation; Mindfulness; Opioids; Prayer; Yoga


  1. Wallace RK., et al. “A wakeful hypometabolic physiologic state”. American Journal of Physiology 221 (1971): 795e9.
  2. Epel E., et al. “Meditation and vacation effects have an impact on disease-associated molecular phenotypes”. Translational Psychiatry 8 (2016): e880-e880.
  3. Zgierska A., et al. “Mindfulness Meditation-Based Intervention Is Feasible, Acceptable, and Safe for Chronic Low Back Pain Requiring Long-Term Daily Opioid Therapy”. The Journal of Alternative and Complementary Medicine 8 (2016): 610-620.
  4. Barnes PM., et al. “Complementary and alternative medicine use among adults and children: United States, 2007”. National Health Statistics Reports 12 (2008): 1-23.
  5. Duerr M., et al. “Survey of Transformative and Spiritual Dimensions of Higher Education”. Journal of Transformative Education 3 (2003): 177-211.
  6. Millstine D., et al. “Use of a Wearable EEG Headband as a Meditation Device for Women with Newly Diagnosed Breast Cancer: A Randomized Controlled Trial”. Integrative Cancer Therapies 18 (2019): 153473541987877.
  7. Hillman CH., et al. “Be smart, exercise your heart: exercise effects on brain and cognition”. Nature Reviews Neuroscience 9 (2008): 58-65.
  8. Cardinali DP. “First level: peripheral sympathetic and parasympathetic nervous system”. In: Autonomic Nervous System. Springer: Cham (2018): 57-111.
  9. Coelho FG., et al. “Physical exercise modulates peripheral levels of brain derived neurotrophic factor (BDNF): a systematic review of experimental studies in the elderly”. Archives of Gerontology and Geriatrics 56 (2013): 10-15.
  10. Zernicke KA., et al. “A randomized wait-list controlled trial of feasibility and efficacy of an online mindfulness-based cancer recovery program: the Therapy for cancer applying mindfulness trial”. Psychosomatic Medicine 76 (2014): 257-267.
  11. Khoury B., et al. “Mindfulness interventions for psychosis: A meta-analysis”. Schizophrenia Research 150 (2013): 176-184.
  12. EB Liddle., et al. “Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate”. Journal of Child Psychology and Psychiatry7 (2011): 761-771.
  13. W Francx., et al. “The executive control network and symptomatic improvement in attention-deficit/hyperactivity disorder”. Cortex 73 (2015): 62-72.
  14. Marcus MT., et al. “Behavioral therapies trials: a case example”. Nursing Research 56 (2007): 210-216.
  15. Davidson R and Kaszniak A. “Conceptual and methodological issues in research on mindfulness and meditation”. American Psychologist7 (2015): 581-592.
  16. Appelhans BM and Luecken LJ. “Heart rate variability as an index of regulated emotional responding”. Review of General Psychology 10 (2006): 229.
  17. Kim YH., et al. “Effects of meditation on anxiety, depression, fatigue, and quality of life of women undergoing radiation therapy for breast cancer”. Complementary Therapies in Medicine 21 (2013): 379-387.
  18. Zeidan F., et al. “Mindfulness-meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia”. The Journal of Neuroscience 35 (2015): 15307-15325.
  19. Zeidan F., et al. “Mindfulness-Meditation-Based Pain Relief Is Not Mediated by Endogenous Opioids”. Journal of Neuroscience 11 (2016): 3391-3397.
  20. Hodgins HS and Adair KC. “Attentional processes and meditation”. Consciousness and Cognition 19 (2010): 872-878.
  21. Cairncross M and Miller CJ. “The effectiveness of mindfulness-based therapies for ADHD: a meta-analytic review”. Journal of Attention Disorders (2016): 1-17.
  22. Lude P., et al. “Quality of life in and after spinal cord injury rehabilitation: a longitudinal multicenter study”. Topics in Spinal Cord Injury Rehabilitation 3 (2014): 197-207.
  23. Hearn JH., et al. “Living with chronic neuropathic pain after spinal cord injury: an interpretative phenomenological analysis of community experience”. Disability and Rehabilitation 23 (2015): 2203-2211.
  24. Rajguru P., et al. “ Use of mindfulness meditation in the management of chronic pain: a systematic review of randomized controlled trials”. American Journal of Lifestyle Medicine 9 (2015): 176-184.
  25. Telles S., et al. “A selective review of dharana and dhyana in healthy participants”. Journal of Ayurveda and Integrative Medicine 4 (2016): 255–260.
  26. Cramer H., et al. “Yoga for schizophrenia: a systematic review and meta-analysis”. BMC Psychiatry 13 (2013): 32.
  27. Hearn JH and Cross A. “Mindfulness for pain, depression, anxiety, and quality of life in people with spinal cord injury: a systematic review”. BMC Neurology 20 (2020): 32.
  28. Cramer H., et al. “Yoga for depression: a systematic review and meta-analysis”. Depress Anxiety 20 (2013): 1068-1083.
  29. Flores A., et al. “The use of virtual reality to facilitate mindfulness skills training in dialectical behavioral therapy for spinal cord injury: a case study”. Frontiers in Psychology 9 (2018): 531.
  30. Kabat-Zinn J. “Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness”. Dell: New York, NY (1990).
  31. Murata T., et al. “Individual trait anxiety levels characterizing the properties of Zen meditation”. Neuropsychobiology 50 (2004): 189-194.
  32. Witek-Janusek L., et al. “Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer”. Brain, Behavior, and Immunity 22 (2008): 969-981.
  33. Reich RR., et al. “Mindfulness-based stress reduction in post-treatment breast cancer patients: immediate and sustained effects across multiple symptom clusters”. Journal of Pain and Symptom Management 53 (2017): 85-95.
  34. Thayer JF., et al. “A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health”. Neuroscience and Biobehavioral Reviews 36 (2012): 747-756.
  35. Sachdeva A. “Non Pharmacological Cognitive Enhancers – Current Perspectives”. Journal of Clinical and Diagnostic Research (2015): 01-06.
  36. Gard T., et al. “The potential effects of meditation on age-related cognitive decline: a systematic review”. Annals of the New York Academy of Sciences 1307 (2014): 89-103.
  37. Zeidan F., et al. “Brain mechanisms supporting the modulation of pain by mindfulness meditation”. The Journal of Neuroscience 31 (2011): 5540-5548.
  38. Anthony WA. “The principle of personhood: The field‘s transcendent principle”. Psychiatric Rehabilitation Journal 27 (2004): 205.'s_Transcendent_Principle
  39. Baer RA. “Mindfulness training as a clinical intervention: a conceptual and empirical review”. Clinical Psychology: Science and Practice 10 (2003): 125-143.
  40. Blazer DG. “Section introduction: Spirituality, depression and suicide”. Southern Medical Journal 7 (2007): 733-734.
  41. Kendra Cherry. What is cognition? (2014).
  42. Cheong M., et al. “Meditation-based clinical study to determine the correlation of quantitative electroencephalogram (qEEG) and 24-hour EEG activity”. Medicine (Baltimore)43 (2018): e12557.
  43. Grabovac A., et al. “Pilot study and evaluation of postgraduate course on “The interface between spirituality, religion and psychiatry”. Academic Psychiatry 4 (2008): 332-337.
  44. Kaufman Y., et al. “Cognitive decline in alzheimer disease: Impact of spirituality, religiosity, and QOL”. Neurology18 (2007): 1509-1514.
  45. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York: Delta (1990).
  46. Zgierska A., et al. “Mindfulness Meditation and Cognitive Behavioral Therapy Intervention Reduces Pain Severity and Sensitivity in Opioid-Treated Chronic Low Back Pain: Pilot Findings from a Randomized Controlled Trial”. Pain Medicine10 (2016): 1865-1881.
  47. Harris DB. 10% happier. New York, NY: HarperCollins (2014).
  48. Henschke N., et al. “Behavioural treatment for chronic low-back pain”. Cochrane Database of Systematic Reviews 7 (2010): CD002014.
  49. Krisanaprakornkit T., et al. “Meditation therapy for anxiety disorders”. Cochrane Database of Systematic Reviews 1 (2006): CD004998.
  50. Boldt I., et al. “Nonpharmacological interventions for chronic pain in people with spinal cord injury”. Cochrane Database of Systematic Reviews 11 (2014): CD009177.
  51. S Cortese., et al. “Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies”. American Journal of Psychiatry10 (2012): 1038-1055.
Citation: Abdullah Hafid and Nicholas A Kerna. “Meta-Analysis of the Beneficial Effects of Mindfulness-Based Interventions (MBIs) on the Neurological System and Prevalent Neurological Disorders”. EC Neurology 12.5 (2020): 101-108.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the December issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 20, 2021.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to